Anbio Biotechnology Class A Ordinary Shares (NNNN) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 2.53M | 6.32M | 3.95M | 3.31M |
| Revenue Growth % | -36% | 91.24% | - | - |
| Cost of Goods Sold | 390.51K | 2.1M | 2.26M | 1.36M |
| COGS % of Revenue | 15.45% | 33.15% | 57.18% | 41.27% |
| Gross Profit | 2.14M | 4.23M | 1.69M | 1.94M |
| Gross Margin % | 84.55% | 66.85% | 42.82% | 58.73% |
| Gross Profit Growth % | 26.38% | 117.67% | - | - |
| Operating Expenses | 3.87M | 337.5K | 1.11M | 406.06K |
| OpEx % of Revenue | 153.19% | 5.34% | 28.04% | 12.28% |
| Selling, General & Admin | 3.52M | 199.48K | 962.08K | 406.06K |
| SG&A % of Revenue | 139.21% | 3.16% | 24.35% | 12.28% |
| Research & Development | 353.47K | 138.03K | 145.7K | 0 |
| R&D % of Revenue | 13.98% | 2.18% | 3.69% | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 |
| Operating Income | -1.74M | 3.89M | 583.74K | 1.54M |
| Operating Margin % | -68.64% | 61.51% | 14.78% | 46.45% |
| Operating Income Growth % | -397.26% | 153.25% | - | - |
| EBITDA | -1.32M | 3.89M | 587.28K | 1.55M |
| EBITDA Margin % | -52.4% | 61.48% | 14.87% | 46.74% |
| EBITDA Growth % | -325.58% | 151.57% | - | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 3.54K | 9.49K |
| EBIT | -1.32M | 3.89M | 792.93K | 1.64M |
| Net Interest Income | 215.47K | 149.66K | 160.06K | 18.75K |
| Interest Income | 215.47K | 149.66K | 160.06K | 18.75K |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income/Expense | 410.48K | -1.86K | 209.19K | 107.39K |
| Pretax Income | -1.32M | 3.89M | 792.93K | 1.64M |
| Pretax Margin % | -52.4% | 61.48% | 20.07% | 49.7% |
| Income Tax | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% |
| Net Income | -1.32M | 3.89M | 792.93K | 1.64M |
| Net Margin % | -52.4% | 61.48% | 20.07% | 49.7% |
| Net Income Growth % | -267.07% | 136.58% | - | - |
| Net Income (Continuing) | -1.32M | 3.89M | 792.93K | 1.64M |
| Discontinued Operations | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.03 | 0.09 | 0.02 | 0.04 |
| EPS Growth % | -267.38% | 136.25% | - | - |
| EPS (Basic) | -0.03 | 0.09 | 0.02 | 0.04 |
| Diluted Shares Outstanding | 42.29M | 42.29M | 42.29M | 42.29M |
| Basic Shares Outstanding | 42.29M | 42.29M | 42.29M | 42.29M |
| Dividend Payout Ratio | - | - | - | - |